Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV5/24/2024 | Chg.+1.3400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,034.2400EUR | +0.07% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 5/27/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 3/1/2024 | PRIIP Key Information Document | 2024 | German | 269.24 KB |
| 12/31/2023 | Account statment | 2023 | English | 5,416.37 KB |
| 12/31/2023 | Account statment | 2023 | German | 4,732.66 KB |
| 9/11/2023 | Prospectus | 2023 | English | 3,638.77 KB |
| 9/11/2023 | Prospectus | 2023 | German | 3,801.35 KB |
| 6/30/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 6/30/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 7/2/2022 | Key Investor Information | 2022 | German | 363.91 KB |
